Daniel Janney's Net Worth

$440 Million

Who is Daniel Janney?

Daniel Janney has an estimated net worth of $440 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., ZS Pharma, Inc., SUTRO BIOPHARMA, INC., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., ANESIVA, INC., ATS MEDICAL INC, RENOVIS INC, Allakos Inc., CUTERA INC, DYNAVAX TECHNOLOGIES CORP, NeurogesX Inc, ACELRX PHARMACEUTICALS INC, ICAGEN INC, FLAMEL TECHNOLOGIES SA, INTARCIA THERAPEUTICS, INC, TorreyPines Therapeutics, Inc., OCCAM NETWORKS INC/DE, COTHERIX INC, Krystal Biotech, Inc., Tyra Biosciences, Inc., Carbylan Therapeutics, Inc., Esperion Therapeutics, Inc., AERIE PHARMACEUTICALS INC, VIVEVE MEDICAL, INC., and ELLIE MAE INC.

SEC CIK

Daniel Janney's CIK is 0001198325

Past Insider Trading and Trends

2014 was Daniel Janney's most active year for acquiring shares with 27 total transactions. Daniel Janney's most active month to acquire stocks was the month of January. 2014 was Daniel Janney's most active year for disposing of shares, totalling 27 transactions. Daniel Janney's most active month to dispose stocks was the month of January. 2014 saw Daniel Janney paying a total of $28,496,905.70 for 16,804,389 shares, this is the most they've acquired in one year. In 2003 Daniel Janney cashed out on 3,325,000 shares for a total of $63,177,849.99, their largest year based on trade value.